Revance Therapeutics, Inc. (RVNC)
USD 3.65
(0.0%)
USD 3.65
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -290.63 Million USD | 14.31% |
| 2022 | -305.51 Million USD | 7.47% |
| 2021 | -255.18 Million USD | 0.85% |
| 2020 | -259.31 Million USD | -65.39% |
| 2019 | -156.52 Million USD | -14.24% |
| 2018 | -137.79 Million USD | -19.53% |
| 2017 | -118.66 Million USD | -48.51% |
| 2016 | -86.74 Million USD | -8.43% |
| 2015 | -70.29 Million USD | -38.62% |
| 2014 | -49.99 Million USD | -35.24% |
| 2013 | -35.4 Million USD | 6.94% |
| 2012 | -27.52 Million USD | -62.33% |
| 2011 | -25.09 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -33.14 Million USD | 28.2% |
| 2024 Q1 | -44.08 Million USD | 13.49% |
| 2023 Q3 | -39.74 Million USD | 34.65% |
| 2023 FY | - USD | 14.31% |
| 2023 Q4 | -51.68 Million USD | -30.05% |
| 2023 Q2 | -60.81 Million USD | -14.12% |
| 2023 Q1 | -53.29 Million USD | 5.11% |
| 2022 Q4 | -56.16 Million USD | 16.7% |
| 2022 FY | - USD | 7.47% |
| 2022 Q1 | -56.99 Million USD | 1.6% |
| 2022 Q2 | -50.89 Million USD | 10.7% |
| 2022 Q3 | -67.41 Million USD | -32.48% |
| 2021 Q3 | -67.63 Million USD | -3.16% |
| 2021 Q2 | -65.56 Million USD | 0.32% |
| 2021 Q1 | -65.77 Million USD | 10.94% |
| 2021 Q4 | -57.91 Million USD | 14.37% |
| 2021 FY | - USD | 0.85% |
| 2020 Q2 | -54.86 Million USD | 6.79% |
| 2020 Q1 | -58.85 Million USD | -30.02% |
| 2020 FY | - USD | -65.39% |
| 2020 Q4 | -73.86 Million USD | 0.58% |
| 2020 Q3 | -74.29 Million USD | -35.42% |
| 2019 Q1 | -34.58 Million USD | 8.08% |
| 2019 FY | - USD | -14.24% |
| 2019 Q4 | -45.26 Million USD | -11.47% |
| 2019 Q3 | -40.6 Million USD | -8.54% |
| 2019 Q2 | -37.41 Million USD | -8.17% |
| 2018 Q3 | -32.34 Million USD | 7.19% |
| 2018 FY | - USD | -19.53% |
| 2018 Q1 | -34.95 Million USD | -7.3% |
| 2018 Q2 | -34.84 Million USD | 0.31% |
| 2018 Q4 | -37.62 Million USD | -16.33% |
| 2017 FY | - USD | -48.51% |
| 2017 Q1 | -26.54 Million USD | -36.46% |
| 2017 Q2 | -26.26 Million USD | 1.07% |
| 2017 Q3 | -30.12 Million USD | -14.73% |
| 2017 Q4 | -32.58 Million USD | -8.14% |
| 2016 Q1 | -19.21 Million USD | 11.88% |
| 2016 FY | - USD | -8.43% |
| 2016 Q4 | -19.45 Million USD | -13.19% |
| 2016 Q3 | -17.18 Million USD | 20.43% |
| 2016 Q2 | -21.59 Million USD | -12.41% |
| 2015 FY | - USD | -38.62% |
| 2015 Q3 | -18.79 Million USD | -13.14% |
| 2015 Q4 | -21.8 Million USD | -16.0% |
| 2015 Q2 | -16.61 Million USD | -9.35% |
| 2015 Q1 | -15.19 Million USD | -8.68% |
| 2014 Q2 | -12.42 Million USD | -13.02% |
| 2014 Q1 | -10.99 Million USD | -18.27% |
| 2014 Q4 | -13.98 Million USD | -1.2% |
| 2014 FY | - USD | -35.24% |
| 2014 Q3 | -13.81 Million USD | -11.17% |
| 2013 Q2 | -10.89 Million USD | -18.12% |
| 2013 Q1 | -9.22 Million USD | 48.63% |
| 2013 FY | - USD | 6.94% |
| 2013 Q4 | -9.29 Million USD | -18.72% |
| 2013 Q3 | -7.83 Million USD | 28.11% |
| 2012 FY | - USD | -62.33% |
| 2012 Q4 | -17.95 Million USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AbCellera Biologics Inc. | -192.15 Million USD | -51.249% |
| Alkermes plc | 495.04 Million USD | 158.709% |
| Agenus Inc. | -145.92 Million USD | -99.17% |
| Aptorum Group Limited | -9.59 Million USD | -2927.785% |
| Ardelyx, Inc. | -55.35 Million USD | -425.051% |
| Dyadic International, Inc. | -8.22 Million USD | -3431.546% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -99775.258% |
| Lantern Pharma Inc. | -15.78 Million USD | -1741.026% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -1359.578% |
| Novavax, Inc. | -487.39 Million USD | 40.369% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -309.21% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -270.271% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -1517.035% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -2815.7% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -406.549% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | 23.51% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1105.368% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 55040.832% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -84.889% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -288.475% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -1341.723% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -1124.508% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -1160.461% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -138.026% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | -12.544% |
| AlloVir, Inc. | -190.14 Million USD | -52.849% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -65.443% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -893.359% |
| Bicycle Therapeutics plc | -183.4 Million USD | -58.472% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -75.695% |
| ChromaDex Corporation | -3.89 Million USD | -7363.713% |
| Chimerix, Inc. | -92.97 Million USD | -212.6% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -554.047% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -158.266% |
| CRISPR Therapeutics AG | -202.7 Million USD | -43.382% |
| Precision BioSciences, Inc. | -32.04 Million USD | -807.05% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -68.75% |
| Fortress Biotech, Inc. | -133.64 Million USD | -117.473% |
| Fortress Biotech, Inc. | -133.64 Million USD | -117.473% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -275.777% |
| ImmuCell Corporation | -2.5 Million USD | -11506.552% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -122.845% |
| Immix Biopharma, Inc. | -16.13 Million USD | -1701.211% |
| Incyte Corporation | 919.42 Million USD | 131.611% |
| Innoviva, Inc. | 248.96 Million USD | 216.74% |
| IO Biotech, Inc. | -91.22 Million USD | -218.583% |
| Jaguar Health, Inc. | -33.13 Million USD | -777.236% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -90.986% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 385.703% |
| ContextLogic Inc. | -324 Million USD | 10.297% |
| MiMedx Group, Inc. | 40.51 Million USD | 817.321% |
| MEI Pharma, Inc. | 26.38 Million USD | 1201.732% |
| NextCure, Inc. | -59.03 Million USD | -392.28% |
| Onconetix, Inc. | -36.7 Million USD | -691.781% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 13103.893% |
| Opthea Limited | -200.01 Million USD | -45.305% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -10462.55% |
| Vaxcyte, Inc. | -464.88 Million USD | 37.482% |
| PDS Biotechnology Corporation | -40.08 Million USD | -625.052% |
| Precigen, Inc. | -89.22 Million USD | -225.731% |
| Pharming Group N.V. | 9.87 Million USD | 3042.564% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -82.734% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -1176.852% |
| PureTech Health plc | -11.62 Million USD | -2399.673% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -1611.542% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -24.471% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1105.368% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -232.434% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -903.477% |
| Acelyrin, Inc. | -381.52 Million USD | 23.822% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -2255542.074% |
| Summit Therapeutics Inc. | 1 Million USD | 29134.665% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -770.536% |
| Senti Biosciences, Inc. | -61.33 Million USD | -373.844% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -158.795% |
| Elevation Oncology, Inc. | -41.46 Million USD | -600.887% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -840.451% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -4651.652% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -90441.121% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -795.563% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -3361.613% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -394.365% |
| Seer, Inc. | -97.88 Million USD | -196.917% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -367.285% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -344.637% |
| ESSA Pharma Inc. | -26.45 Million USD | -998.596% |
| GlycoMimetics, Inc. | -39.12 Million USD | -642.899% |
| GT Biopharma, Inc. | 5.97 Million USD | 4960.963% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -40.613% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -4131.756% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 434.789% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -412.1% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -467.44% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -2839.616% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 46.171% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -4121.92% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -520.198% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -22.828% |
| Aptose Biosciences Inc. | -52.26 Million USD | -456.052% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -169.749% |
| Soligenix, Inc. | -7.85 Million USD | -3601.038% |
| Century Therapeutics, Inc. | -121.2 Million USD | -139.784% |
| Kura Oncology, Inc. | -164.95 Million USD | -76.192% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -262.852% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -2781.588% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -30246.159% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -6644.883% |
| Autolus Therapeutics plc | -156.77 Million USD | -85.391% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -243.311% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -321.207% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -1357.996% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -53.554% |
| GRI Bio, Inc. | -10.89 Million USD | -2566.884% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -6336.124% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -137.243% |
| IGM Biosciences, Inc. | -253.35 Million USD | -14.714% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -180.019% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -662.162% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -1795.759% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -1746.106% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -411.28% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -171.362% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | -9.263% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -49.86% |
| Verastem, Inc. | -83.16 Million USD | -249.466% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -474.699% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -83.682% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -154.746% |
| Histogen Inc. | -10.5 Million USD | -2667.181% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -1935.315% |
| Surrozen, Inc. | -41.13 Million USD | -606.613% |
| Organovo Holdings, Inc. | -14.8 Million USD | -1862.968% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 9062681.852% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -395.012% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -466.61% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -1249.352% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -3385.69% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -75.013% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -490.024% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -1102.669% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -1830.496% |
| Apollomics, Inc. | -171.74 Million USD | -69.224% |
| Amarin Corporation plc | -50.9 Million USD | -470.979% |
| Mesoblast Limited | -61.33 Million USD | -373.883% |
| Turnstone Biologics Corp. | -56.23 Million USD | -416.835% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -102.957% |
| Synaptogenix, Inc. | -8.3 Million USD | -3398.486% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -1794.758% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -360.985% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -5965.722% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 67841.394% |
| Exelixis, Inc. | 196.6 Million USD | 247.83% |
| Better Therapeutics, Inc. | -38.26 Million USD | -659.597% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -105.529% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 41.31% |
| NLS Pharmaceutics AG | -11.79 Million USD | -2363.933% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 117663.993% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -885.01% |
| Gritstone bio, Inc. | -126.86 Million USD | -129.095% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -347.237% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -7166.023% |
| Avid Bioservices, Inc. | -11.48 Million USD | -2431.461% |
| Insmed Incorporated | -654.73 Million USD | 55.61% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -12818.813% |
| MediWound Ltd. | -4.89 Million USD | -5839.853% |
| OmniAb, Inc. | -49.73 Million USD | -484.418% |
| Alector, Inc. | -142.89 Million USD | -103.396% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -240.189% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -457.331% |
| Zai Lab Limited | -366.57 Million USD | 20.715% |
| Aura Biosciences, Inc. | -83.69 Million USD | -247.253% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -29.029% |
| Immunic, Inc. | -99.11 Million USD | -193.241% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -120.731% |
| Veracyte, Inc. | -49.4 Million USD | -488.227% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -4014.381% |
| FibroGen, Inc. | -261.4 Million USD | -11.183% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -2508.716% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -4051.17% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -1452.808% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 120.052% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -1043.25% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 828.596% |
| TG Therapeutics, Inc. | 26.1 Million USD | 1213.552% |
| Galecto, Inc. | -37.51 Million USD | -674.64% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -659.537% |
| Fortrea Holdings Inc. | 167.3 Million USD | 273.722% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -116.441% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -926.587% |
| XBiotech Inc. | -35.76 Million USD | -712.607% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -347.237% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -345.421% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -178.241% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1032.117% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -611.178% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 43.725% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -418.8% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -518422.417% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -149.828% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -1210.974% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -23.642% |
| NexImmune, Inc. | -28.16 Million USD | -931.816% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -5159.876% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -2364.64% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 106.245% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -1044.601% |
| Scopus BioPharma Inc. | -11.71 Million USD | -2381.288% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -130.947% |
| Ainos, Inc. | -8.77 Million USD | -3212.821% |
| Pluri Inc. | -20.22 Million USD | -1337.019% |
| Prothena Corporation plc | -190.1 Million USD | -52.88% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -126.709% |
| Celularity Inc. | -183.94 Million USD | -58.001% |
| Rallybio Corporation | -72.37 Million USD | -301.582% |
| Cue Biopharma, Inc. | -46.05 Million USD | -531.106% |
| MeiraGTx Holdings plc | -57.05 Million USD | -409.425% |
| Omeros Corporation | -163.61 Million USD | -77.64% |
| Humacyte, Inc. | -96.45 Million USD | -201.309% |
| Immunocore Holdings plc | -59.64 Million USD | -387.245% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -1400.294% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -1092.846% |
| Blueprint Medicines Corporation | -474.61 Million USD | 38.763% |
| CalciMedica, Inc. | -34.18 Million USD | -750.089% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -296.861% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -131.589% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -72.535% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -15.154% |
| Pulmatrix, Inc. | -12.64 Million USD | -2198.252% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -781.627% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -228.526% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 42.598% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -187.148% |
| Cytokinetics, Incorporated | -456.68 Million USD | 36.359% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -770.875% |
| Nutriband Inc. | -5.12 Million USD | -5574.534% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -571.651% |
| Vor Biopharma Inc. | -114.37 Million USD | -154.118% |
| Roivant Sciences Ltd. | -996.51 Million USD | 70.835% |
| Evogene Ltd. | -23.2 Million USD | -1152.53% |
| ProKidney Corp. | -147.66 Million USD | -96.817% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -350.356% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -189674.011% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 48.602% |
| CorMedix Inc. | -48.88 Million USD | -494.507% |
| BioLineRx Ltd. | -57.06 Million USD | -409.344% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -160.059% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -143779.703% |
| Atai Life Sciences N.V. | -36.31 Million USD | -700.41% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -265.503% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -257.43% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | -5.493% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -845.468% |
| MediciNova, Inc. | -9.87 Million USD | -2841.679% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -130.772% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -18893.387% |
| GeoVax Labs, Inc. | -26.66 Million USD | -989.803% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -29.177% |
| Biomea Fusion, Inc. | -124.62 Million USD | -133.219% |
| PTC Therapeutics, Inc. | -330.34 Million USD | 12.019% |
| Mereo BioPharma Group plc | -26.05 Million USD | -1015.432% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -52.694% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -26.396% |
| Absci Corporation | -95.45 Million USD | -204.469% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -867.983% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -171.324% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -24.483% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -1171.656% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -39.84% |
| Allakos Inc. | -189.91 Million USD | -53.035% |
| Imunon, Inc. | -19.87 Million USD | -1362.083% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -167.888% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 368.303% |
| BioAtla, Inc. | -122.24 Million USD | -137.757% |
| NLS Pharmaceutics AG | -11.79 Million USD | -2363.933% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -1744.026% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | 3.216% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -601.226% |
| XOMA Corporation | -39.36 Million USD | -638.369% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -192.821% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -147.035% |
| aTyr Pharma, Inc. | -52.17 Million USD | -457.011% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -246.76% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -95.543% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -23.905% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -2028.741% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -3513.854% |
| Akari Therapeutics, Plc | -16.8 Million USD | -1629.776% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 154115.771% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 164.308% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -4449.289% |
| UroGen Pharma Ltd. | -63.83 Million USD | -355.323% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -327.942% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -3901.604% |
| Orgenesis Inc. | -60.71 Million USD | -378.667% |
| Entera Bio Ltd. | -8.8 Million USD | -3201.193% |
| GH Research PLC | -41.15 Million USD | -606.235% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -1038.904% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -253.431% |
| Xencor, Inc. | -125.87 Million USD | -130.895% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -20273.49% |
| Replimune Group, Inc. | -230.19 Million USD | -26.255% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -1341.822% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -2556.16% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -4449.289% |
| Portage Biotech Inc. | -18.19 Million USD | -1496.994% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -18893.387% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -177.898% |
| OncoCyte Corporation | -23.12 Million USD | -1156.917% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -2471.926% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -2436.799% |
| Purple Biotech Ltd. | -22.22 Million USD | -1207.703% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -4434.119% |
| scPharmaceuticals Inc. | -46.06 Million USD | -530.983% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -1531.904% |
| HilleVax, Inc. | -132.46 Million USD | -119.405% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -2633.349% |
| Tharimmune, Inc. | -9.3 Million USD | -3024.259% |
| Genprex, Inc. | -31.06 Million USD | -835.711% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -54.985% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -826.953% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -37941.492% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 192697.28% |
| OKYO Pharma Limited | -15.74 Thousand USD | -1845698.295% |
| Savara Inc. | -59.13 Million USD | -391.497% |
| Curis, Inc. | -45.13 Million USD | -543.871% |
| Daré Bioscience, Inc. | -30.7 Million USD | -846.654% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -1813.2% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -3956.343% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -987.144% |
| BeiGene, Ltd. | -1.12 Billion USD | 74.157% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -1682.918% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | 32.501% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -221.715% |
| Erasca, Inc. | -121.31 Million USD | -139.582% |
| bluebird bio, Inc. | -167.16 Million USD | -73.867% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -6360.386% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 193.668% |
| DBV Technologies S.A. | -85.98 Million USD | -238.021% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -6360.386% |
| Moderna, Inc. | -3.28 Billion USD | 91.147% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -582.102% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -5045.839% |
| Molecular Templates, Inc. | 1.43 Million USD | 20424.266% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -385.593% |
| Travere Therapeutics, Inc. | -326.24 Million USD | 10.915% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -112.006% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -513.598% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -109.04% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -41.182% |
| MacroGenics, Inc. | 2.01 Million USD | 14509.37% |
| RenovoRx, Inc. | -11.39 Million USD | -2451.686% |
| Adicet Bio, Inc. | -136.53 Million USD | -112.866% |
| Prime Medicine, Inc. | -193.75 Million USD | -49.999% |
| Aditxt, Inc. | -25.45 Million USD | -1041.635% |
| Adagene Inc. | -14.95 Million USD | -1843.958% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3875.829% |
| Quantum-Si incorporated | -91.8 Million USD | -216.584% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 140.796% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 329.834% |
| SciSparc Ltd. | -5.28 Million USD | -5402.404% |
| Vericel Corporation | 2.86 Million USD | 10247.94% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -305165.314% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -1239.87% |
| Generation Bio Co. | -133.3 Million USD | -118.032% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -250.039% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -237.86% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -27.79% |
| Invivyd, Inc. | -196.61 Million USD | -47.82% |
| Relay Therapeutics, Inc. | -374.15 Million USD | 22.321% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -3033.621% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 1170.328% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -2725.834% |
| 2seventy bio, Inc. | -206.41 Million USD | -40.8% |
| ADMA Biologics, Inc. | 5.12 Million USD | 5776.504% |
| Clene Inc. | -43.24 Million USD | -572.133% |
| Capricor Therapeutics, Inc. | -23 Million USD | -1163.146% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -499.536% |
| GeoVax Labs, Inc. | -26.66 Million USD | -989.803% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | 2.981% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -691.294% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 1332.923% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 6018.98% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -794.763% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -83.478% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 57.528% |
| Evaxion Biotech A/S | -21.4 Million USD | -1257.926% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -337.607% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -33.522% |
| Trevena, Inc. | -35.28 Million USD | -723.614% |
| Surrozen, Inc. | -41.13 Million USD | -606.613% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -265.159% |
| Cingulate Inc. | -22.95 Million USD | -1166.28% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -3795.416% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -679.543% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -3432.992% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -184.197% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -328.498% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -397.905% |
| Clearmind Medicine Inc. | -8.71 Million USD | -3236.566% |
| Kronos Bio, Inc. | -121.83 Million USD | -138.559% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -290.946% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -11804.454% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -188.253% |
| Statera Biopharma, Inc. | 38.93 Million USD | 846.468% |
| ImmunityBio, Inc. | -436.18 Million USD | 33.368% |
| Korro Bio, Inc. | -80.9 Million USD | -259.237% |
| Kineta, Inc. | -15.71 Million USD | -1749.542% |
| BioVie Inc. | -31.95 Million USD | -809.656% |
| Codexis, Inc. | -49.28 Million USD | -489.731% |
| Celularity Inc. | -183.94 Million USD | -58.001% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -31.207% |
| Celcuity Inc. | -58.3 Million USD | -398.435% |
| Virax Biolabs Group Limited | -6.6 Million USD | -4297.498% |
| Cibus, Inc. | -314.58 Million USD | 7.613% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -761.581% |
| IN8bio, Inc. | -28.5 Million USD | -919.636% |
| Kodiak Sciences Inc. | -259.02 Million USD | -12.205% |
| Annexon, Inc. | -141.57 Million USD | -105.288% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -158.117% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -352.734% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -939.66% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -26.358% |
| Eyenovia, Inc. | -24.1 Million USD | -1105.661% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 748.975% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -89602.778% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -293.796% |
| Arcellx, Inc. | -64.14 Million USD | -353.094% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -545.659% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -135.379% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -841.121% |
| Moolec Science SA | -52.07 Million USD | -458.107% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -463.185% |
| Geron Corporation | -174.78 Million USD | -66.285% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -619.096% |
| Royalty Pharma plc | 1.88 Billion USD | 115.4% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -143.022% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -3017.0% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -1301.285% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -74.998% |
| Humacyte, Inc. | -96.45 Million USD | -201.309% |
| Structure Therapeutics Inc. | -102.45 Million USD | -183.662% |
| 89bio, Inc. | -134.46 Million USD | -116.146% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -268.478% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 7272.68% |
| Genelux Corporation | -24.16 Million USD | -1102.719% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -759.873% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -77.799% |
| Notable Labs, Ltd. | -14.4 Million USD | -1918.313% |
| Liquidia Corporation | -70.05 Million USD | -314.893% |
| Mustang Bio, Inc. | -48.06 Million USD | -504.7% |
| Immunovant, Inc. | -269.97 Million USD | -7.652% |
| Quantum-Si incorporated | -91.8 Million USD | -216.584% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -309.429% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -1405.267% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -184.905% |
| Acasti Pharma Inc. | -11.3 Million USD | -2471.781% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -1206.043% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -1795.759% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -38.061% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -6705.94% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -1730.208% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -909.998% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -684.869% |
| PepGen Inc. | -83.58 Million USD | -247.727% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -885.077% |
| United Therapeutics Corporation | 1.38 Billion USD | 120.957% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1169.323% |
| Solid Biosciences Inc. | -93.43 Million USD | -211.061% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -5990.802% |
| Immuneering Corporation | -58.06 Million USD | -400.574% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 9062681.852% |
| Silo Pharma, Inc. | -3.62 Million USD | -7914.888% |
| Belite Bio, Inc | -31.52 Million USD | -821.808% |
| XOMA Corporation | -39.36 Million USD | -638.369% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -330.912% |
| Bionomics Limited | -9.83 Million USD | -2854.53% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -246.058% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -739.846% |
| uniQure N.V. | -253.1 Million USD | -14.831% |
| Cassava Sciences, Inc. | -95.68 Million USD | -203.737% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3875.829% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -124.423% |
| Forte Biosciences, Inc. | -32.47 Million USD | -794.901% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -3510.185% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -929.934% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -89602.778% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -2508.716% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -1727.791% |
| Altimmune, Inc. | -87.93 Million USD | -230.513% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -215.639% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -739.846% |
| Compugen Ltd. | -12.51 Million USD | -2222.124% |
| Peak Bio, Inc. | -1356.23 USD | -21429672.236% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -498.043% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1192.294% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -19.948% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -918.243% |
| Zura Bio Limited | -60.56 Million USD | -379.892% |
| PolyPid Ltd. | -20.26 Million USD | -1334.324% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -1761.506% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -918.243% |
| Instil Bio, Inc. | -146.12 Million USD | -98.9% |
| argenx SE | -216.02 Million USD | -34.54% |
| Immunome, Inc. | -28.27 Million USD | -928.039% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -499.585% |
| Verona Pharma plc | -52.46 Million USD | -453.936% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -206.67% |
| Shattuck Labs, Inc. | -87.61 Million USD | -231.721% |
| CervoMed Inc. | -2.17 Million USD | -13281.854% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -137.752% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -2189.742% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -503.307% |
| Moolec Science SA | -52.07 Million USD | -458.107% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -1595.667% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -122.896% |
| AnaptysBio, Inc. | -143.16 Million USD | -103.01% |
| Design Therapeutics, Inc. | -66.32 Million USD | -338.201% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -258.869% |
| NeurAxis, Inc. | -6.66 Million USD | -4260.976% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -669.899% |
| Lumos Pharma, Inc. | -36.57 Million USD | -694.742% |
| Achilles Therapeutics plc | -70.44 Million USD | -312.59% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -206.67% |
| 180 Life Sciences Corp. | -22.13 Million USD | -1213.078% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 5085.841% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -11804.454% |
| Nutriband Inc. | -5.12 Million USD | -5574.534% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -164.822% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -424.313% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -474.95% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -345.236% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -437.123% |
| Palisade Bio, Inc. | -12.28 Million USD | -2266.558% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -540.508% |
| Beam Therapeutics Inc. | -156.47 Million USD | -85.743% |
| Neurogene Inc. | -52.28 Million USD | -455.86% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -112.936% |
| AEON Biopharma, Inc. | -48.36 Million USD | -500.974% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -212.452% |
| Sesen Bio, Inc. | -50.84 Million USD | -471.67% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -254.73% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -2253.332% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | 32.004% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -176.279% |
| Athira Pharma, Inc. | -116.7 Million USD | -149.04% |
| Vaccinex, Inc. | -19.74 Million USD | -1371.729% |
| HCW Biologics Inc. | -23.57 Million USD | -1132.763% |
| XOMA Corporation | -39.36 Million USD | -638.369% |
| Nektar Therapeutics | -243.1 Million USD | -19.551% |
| Arvinas, Inc. | -394.8 Million USD | 26.384% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 154115.771% |
| Merus N.V. | -149.2 Million USD | -94.788% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -210.875% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -829.741% |
| Rezolute, Inc. | -68.42 Million USD | -324.765% |
| Clene Inc. | -43.24 Million USD | -572.133% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -1784.538% |
| BeyondSpring Inc. | -21.54 Million USD | -1249.29% |
| Synlogic, Inc. | -55.16 Million USD | -426.889% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -2305.338% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -2631.037% |
| Peak Bio, Inc. | -1356.23 USD | -21429672.236% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -795.232% |
| Krystal Biotech, Inc. | 17.9 Million USD | 1723.308% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -145.423% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | 14.856% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -6209.374% |
| MannKind Corporation | 15.12 Million USD | 2021.059% |
| Ikena Oncology, Inc. | -74.39 Million USD | -290.657% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -2207.925% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 1529.808% |
| Gossamer Bio, Inc. | -172.15 Million USD | -68.826% |
| CohBar, Inc. | -12.06 Million USD | -2308.775% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -1039.351% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -867.983% |
| Legend Biotech Corporation | -477.87 Million USD | 39.181% |
| Mural Oncology plc | -192.72 Million USD | -50.808% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -154.824% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -1700.137% |
| Disc Medicine, Inc. | -91.02 Million USD | -219.294% |
| Champions Oncology, Inc. | -5.05 Million USD | -5650.633% |
| REGENXBIO Inc. | -239.46 Million USD | -21.37% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -2611.625% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -421.266% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -649.678% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -157.643% |
| Vaxart, Inc. | -74.72 Million USD | -288.953% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -725.479% |
| Cellectis S.A. | -98.09 Million USD | -196.281% |
| Longeveron Inc. | -20.06 Million USD | -1348.838% |
| Repare Therapeutics Inc. | -114.27 Million USD | -154.336% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | 33.825% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -288.49% |
| Revolution Medicines, Inc. | -430.58 Million USD | 32.501% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -4521.355% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -843.964% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -289.646% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 6027.738% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -2550.588% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 106.311% |
| Denali Therapeutics Inc. | -179.97 Million USD | -61.489% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -305165.314% |
| Veru Inc. | -89.97 Million USD | -223.018% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -981.319% |
| Cingulate Inc. | -22.95 Million USD | -1166.28% |
| Passage Bio, Inc. | -98.34 Million USD | -195.54% |
| Context Therapeutics Inc. | -25.06 Million USD | -1059.738% |
| Exicure, Inc. | -15.53 Million USD | -1770.371% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -41.042% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -686.015% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -4774.337% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -72.522% |
| Nuvalent, Inc. | -149.49 Million USD | -94.416% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -3473.809% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -238.367% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -863.076% |
| OmniAb, Inc. | -49.73 Million USD | -484.418% |
| Anew Medical, Inc. | -1.3 Million USD | -22242.256% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -2250.671% |
| Lipocine Inc. | -16.32 Million USD | -1680.573% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -335.934% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -291.151% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -662.162% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -644.956% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -1210.179% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 46.679% |
| Ocugen, Inc. | -64.82 Million USD | -348.327% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -213.965% |
| Q32 Bio Inc. | -86.5 Million USD | -235.989% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -1617.002% |
| Alumis Inc. Common Stock | -156.89 Million USD | -85.249% |
| Equillium, Inc. | -12.13 Million USD | -2294.439% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -397.053% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -3577.39% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -1440.944% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -522.456% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -173.296% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -1524.888% |
| Dominari Holdings Inc. | -22.44 Million USD | -1195.174% |
| Edesa Biotech, Inc. | -8.19 Million USD | -3448.62% |
| vTv Therapeutics Inc. | -25.41 Million USD | -1043.7% |
| Bio-Techne Corporation | 326.66 Million USD | 188.972% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | 24.483% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 234.312% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -121.678% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -676.461% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -92.346% |
| Nkarta, Inc. | -120.48 Million USD | -141.231% |
| BioCardia, Inc. | -11.56 Million USD | -2414.161% |
| Iterum Therapeutics plc | -34.58 Million USD | -740.477% |